Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Free Radical Biology & Medicine|March 5, 2013
Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injuryMohamed A Abdelmegeed, Sehwan Jang, Atrayee Banerjee, et al.
Advances in Pharmacology (San Diego, Calif.)|August 3, 2015
Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver DiseaseByoung-Joon Song, Mohammed Akbar, Inho Jo, et al.
Drug Development Research|June 30, 2012
Purification and Recognition of Recombinant Mouse P2X(1) Receptors Expressed in a Baculovirus SystemLiping Chen, James P Hardwick, Peter McPhie, et al.
PPAR Research|March 20, 2010
PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver DiseaseJames P Hardwick, Douglas Osei-Hyiaman, Homer Wiland, et al.
Archives of Biochemistry and Biophysics|February 12, 2008
Genomic structure and regulation of the rat hepatic CYP4F1 gene by peroxisome proliferatorsEllen Donelson, Liping Chen, Xiaolan Zhang, et al.
Archives of Biochemistry and Biophysics|July 10, 1995
Fatty acid discrimination and omega-hydroxylation by cytochrome P450 4A1 and a cytochrome P4504A1/NADPH-P450 reductase fusion proteinM A Alterman, C S Chaurasia, P Lu, et al.
The Journal of Nutrition|July 1, 1985
Effect of dietary restriction on liver protein synthesis in ratsM C Birchenall-Sparks, M S Roberts, J Staecker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995
cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purificationJ T Buters, M Shou, J P Hardwick, et al.
Free Radical Biology & Medicine|June 23, 2009
Role of peroxisome proliferator-activated receptor-alpha in fasting-mediated oxidative stressMohamed A Abdelmegeed, Kwan-Hoon Moon, James P Hardwick, et al.
Biochemical Pharmacology|November 19, 2021
CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD)Nicholas Osborne, Charles Leahy, Yoon-Kwang Lee, et al.
Pageof 7